Novartis Net Worth

Novartis Net Worth Analysis

Know Novartis' Top Institutional Investors

Note, although Novartis' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Novartis' market capitalization trends

The company currently falls under 'Mega-Cap' category with a total capitalization of 221.64 B.

Project Novartis' profitablity

The company has Net Profit Margin of 0.23 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.3 %, which entails that for every 100 dollars of revenue, it generated $0.3 of operating income.

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Evaluate Novartis' management efficiency

Novartis AG ADR has Return on Asset of 0.1009 % which means that on every $100 spent on assets, it made $0.1009 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2628 %, implying that it generated $0.2628 on every 100 dollars invested. Novartis' management efficiency ratios could be used to measure how well Novartis manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.13 in 2025. Return On Capital Employed is likely to drop to 0.14 in 2025. At this time, Novartis' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 73.5 B in 2025, whereas Intangible Assets are likely to drop slightly above 22.7 B in 2025.

Novartis Corporate Filings

Novartis time-series forecasting models is one of many Novartis' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Novartis' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Novartis Earnings per Share Projection vs Actual

Novartis Corporate Directors

Additional Tools for Novartis Stock Analysis